abstract |
The present invention relates to the compounds of formula (I): n n n n n n n n n n in which: n n n n n n n n n n and the remaining variables are defined herein. The present invention also relates to a process for preparing such compounds and use of such compounds in the treatment of a chemokine (such as CCR3) or H1 mediated disease state. |